GSK's former Consumer Healthcare Europe and Americas chief, Brian McNamara, fills the vacancy left by GSK CEO-to-be Emma Walmsley. Plus more hirings,…

Becton Dickinson has launched the new, smaller version of its Phoenix antimicrobial resistance diagnostic.

Aurinia Pharmaceuticals has followed up on topline data from its Phase IIb lupus nephritis trial with the publication of details of the secondary endpoints.

Intra-Cellular Therapies shed about $1.2 billion in market cap on the top-line data on a Phase III trial for its ITI-007 to treat schizophrenia that missed the…

Gene therapy player bluebird bio has partnered with German biotech Medigene to develop and commercialize T cell receptor (TCR) immunotherapies against four…

Roche’s Genentech is pairing up with Hanmi Pharmaceutical to gain access to its Phase I pan-RAF inhibitor.

Google Translate creator Franz Och will join Illumina-founded cancer screening company Grail, leaving his post as chief data scientist at Human Longevity,…

Charles River Laboratories’ acquisition spree is keeping the hits coming as the company picked up Massachusetts-based Agilux this week for $64 million. It’s…